All In Biotech

Drug Trial Radar · NCT00289588

An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection in Soldiers

An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus Infection in Soldiers: a Controlled Trial

Last checked: Nov 20, 2026Latest source record: Feb 16, 2006 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 3,000 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

3,000

Actual

Start

Jan 2005

Primary completion

Not stated

Study completion Dec 2005

Sponsor

Lead sponsor
Brooke Army Medical CenterFederal agency
Sponsor type
Federal agency
Collaborators
GlaxoSmithKline; Becton, Dickinson and Company
First posted
Feb 10, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Prevention
Who can join
All sexes, from 17 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The main purpose of this study is to determine if applying mupirocin into soldiers noses who are colonized with methicillin-resistant Staphylococcus aureus (MRSA) will reduce infections in them and their cohort of fellow soldiers.

Conditions

  • Community-Acquired MRSA Infections
  • Abscesses
  • Cellulitis
  • Folliculitis

Interventions

  • Mupirocin (drug)Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Soft tissue infections in subjects who received the study medication and soft tissue infections in the study cohorts.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Brooke Army Medical Center

    Fort Sam Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.